Non-invasive Measuring of Cerebral Perfusion After Severe Brain Injury With Near-infrared-spectroscopy and ICG

April 17, 2013 updated by: Gerrit Brinker, University of Cologne

Continuous, Non-invasive Monitoring of Cerebral Oxygenation and Perfusion Using Near-infrared Spectroscopy With Indocyanine Green Perfusion Measurement in Patients With Traumatic Brain Injury, Intracerebral or Subarachnoid Hemorrhage

The purpose of this study is to show if it is possible to detect secondary ischemic events in patients with severe brain injury or cerebral haemorrhage with the help of non-invasive near-infrared spectroscopy (NIRS) by using the indocyanine green measuring of cerebral perfusion.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cologne, Germany, 50937
        • Departement of General Neurosurgery of th University of Cologne
        • Contact:
        • Contact:
        • Sub-Investigator:
          • Michael Reiner, physician
        • Sub-Investigator:
          • André Pascal Schulte, physician
        • Principal Investigator:
          • Gerrit Brinker, physician

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients over 18 years
  • onset of clinical symptoms of subarachnoid or intracranial haemorrhage or trauma suffered less than 72h
  • indication for implanting a tissue oxygen and intracranial pressure probe
  • A signed informed consent by the patient or legal guardian

Exclusion Criteria:

  • Persistent epidural, subdural or subcutaneous hematoma in planned area of the NIRS optode
  • Open injuries in the area of the planned optodes
  • Malignant primary disease under chemotherapy
  • pregnancy
  • bleeding disorder
  • In the short term unfavorable prognosis (eg, bilateral wide and light-fixed pupils)
  • Patients with pacemakers or where no MRI compatibility is due to non- removable metal parts
  • contraindications for contrast media in CT (eg, iodine allergy)
  • Untreated hyperthyroidism
  • End Stage Renal Disease
  • severe psychomotor agitation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: DIAGNOSTIC
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: indocyanine green
in this arm we do the Intervention 'measuring cerebral perfusion by NIRS with ICG', the pat. gets before a CT-Scan with perfusion measurement a indocyanine green bolus i.v. and a measurement of cerebral perfusion with near-infrared-spectroscopy
application of a bolus of 5mg indocyanine green (ICG) in 3ml saline 0,9% i.v. in 1 second and measuring the ICG turnover with the near-infrared-spectroscopy (NIRS)
Other Names:
  • indocyanine green
  • NIRO-200NX C10488, Hamamatsu Photonics K.K.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
with near-infrared-spectroscopy detected cerebral perfusion deficit
Time Frame: 15 days after ictus
15 days after ictus

Secondary Outcome Measures

Outcome Measure
Time Frame
Determining a threshold value for cerebral autoregulation measured with near-infrared-spectroscopy as a predictive value for the clinical outcome
Time Frame: 15 days after ictus and follow up 6 month later
15 days after ictus and follow up 6 month later

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gerrit Brinker, physician, Universitiy of Cologne, Departement of General Neurosurgery

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2013

Primary Completion (ANTICIPATED)

December 1, 2015

Study Completion (ANTICIPATED)

June 1, 2016

Study Registration Dates

First Submitted

April 17, 2013

First Submitted That Met QC Criteria

April 17, 2013

First Posted (ESTIMATE)

April 22, 2013

Study Record Updates

Last Update Posted (ESTIMATE)

April 22, 2013

Last Update Submitted That Met QC Criteria

April 17, 2013

Last Verified

April 1, 2013

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Traumatic Brain Injury

Clinical Trials on measuring cerebral perfusion by NIRS with ICG

3
Subscribe